nanotech investing Silo Pharma Subsidiary QwikAgents Collaborates with Amazon Web Services Premier Tier Partner Caylent to Advance Enterprise AI Platform
nanotech investing Nuvation Bio Reports Second Quarter 2026 Financial Results and Provides Business Update
nanotech investing Cullinan Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results
nanotech investing Vaxcyte Reports Second Quarter 2026 Financial Results and Provides Business Update
nanotech investing Veru Announces Notice of Allowance for Key Methods of Use U.S. Patent for Enobosarm in Combination with Semaglutide for Quality Weight Loss
nanotech investing Nuvation Bio to Present New Subgroup Analyses of Pivotal Data for IBTROZI® in Advanced ROS1-Positive Non-Small Cell Lung Cancer at WCLC and ESMO Annual Congresses
nanotech investing CEL-SCI Study Published in Peer-Reviewed Oral Oncology Supports Multikine's Biomarker Strategy and Potential Overall Survival Benefit Ahead of Head and Neck Cancer Confirmatory Registration Study
nanotech investing Longeveron to Report 2026 Second Quarter Financial Results and Host Conference Call on August 12, 2026
nanotech investing Leading Oncology Journal Accepts For Publication New CEL-SCI Multikine Phase 3 Data Demonstrating Overall Survival Benefit in Underserved Head and Neck Cancer Patients
nanotech investing Veru to Participate in Fireside Chat at the Canaccord Genuity's 46th Annual Growth Investors Conference
nanotech investing Cullinan Therapeutics Announces Positive End-of-Phase 1 Meeting with FDA for CLN-049 and Advances Program to a Potentially Registrational Phase 2 Study in AML
